{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:27:04Z","timestamp":1793752024050,"version":"4.6.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00120-026-02919-z","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:04:53Z","timestamp":1789373093000},"page":"1216-1227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antikoagulation und Thrombozytenaggregationshemmung in der Urologie","Anticoagulation and platelet aggregation inhibition in urology"],"prefix":"10.1007","volume":"65","author":[{"given":"Melanie","family":"Ostermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura-Maria","family":"Krabbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Krabbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"2919_CR1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3238\/arztebl.m2025.0211","volume":"123","author":"L Kellert","year":"2026","unstructured":"Kellert\u00a0L, Sinner\u00a0MF, H\u00f6llig\u00a0A, Nolte\u00a0CH, Linnemann\u00a0B (2026) Pausieren und Wiederansetzen einer oralen Antikoagulation bei neurologischen und kardiologischen Indikationen. Dtsch Arztebl Int 123:198\u2013206. https:\/\/doi.org\/10.3238\/arztebl.m2025.0211","journal-title":"Dtsch Arztebl Int"},{"key":"2919_CR2","unstructured":"GKV-Spitzenverband (2023) GAmSi-Telegramm. gkv-90prozent.de. Zugegriffen: 8. Mai 2026"},{"key":"2919_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-025-02761-x","author":"M Kunz","year":"2025","unstructured":"Kunz\u00a0M, Daud\u00ed\u00a0AE, Kieble\u00a0M et\u00a0al (2025) Temporal trends in the prescription of low-dose antithrombotic and anti-inflammatory therapies in Germany (2022\u20132024). Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-025-02761-x","journal-title":"Clin Res Cardiol"},{"key":"2919_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-063490","volume":"13","author":"L Warkentin","year":"2023","unstructured":"Warkentin\u00a0L, Klohn\u00a0F, Deiters\u00a0B, K\u00fchlein\u00a0T, Hueber\u00a0S (2023) Vitamin-K-antagonist phenprocoumon versus direct oral anticoagulants in patients with atrial fibrillation: A\u00a0real-world analysis of German claims data. BMJ Open 13:e063490. https:\/\/doi.org\/10.1136\/bmjopen-2022-063490","journal-title":"BMJ Open"},{"key":"2919_CR5","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jacc.2023.10.038","volume":"83","author":"A Bejjani","year":"2024","unstructured":"Bejjani\u00a0A, Khairani\u00a0CD, Assi\u00a0A, Piazza\u00a0G, Sadeghipour\u00a0P, Talasaz\u00a0AH, Fanikos\u00a0J, Connors\u00a0JM, Siegal\u00a0DM, Barnes\u00a0GD, Martin\u00a0KA, Angiolillo\u00a0DJ, Kleindorfer\u00a0D, Monreal\u00a0M, Jimenez\u00a0D, Middeldorp\u00a0S, Elkind\u00a0MSV, Ruff\u00a0CT, Goldhaber\u00a0SZ, Krumholz\u00a0HM, Mehran\u00a0R, Cushman\u00a0M, Eikelboom\u00a0JW, Lip\u00a0GYH, Weitz\u00a0JI, Lopes\u00a0RD, Bikdeli\u00a0B (2024) When direct oral anticoagulants should not be standard treatment: JACC State-of-the-Art Review. JACC Adv 83:444\u2013465. https:\/\/doi.org\/10.1016\/j.jacc.2023.10.038 (Erratum in: J Am Coll Cardiol 2024;83:1351. https:\/\/doi.org\/10.1016\/j.jacc.2024.02.032)","journal-title":"J Am Coll Cardiol"},{"key":"2919_CR6","unstructured":"Fachinformation. Wirkstoff: Phenprocoumon. Zugegriffen: 8. Mai 2026 (fachinfo.de)"},{"key":"2919_CR7","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jama.2024.12708","volume":"332","author":"JD Douketis","year":"2024","unstructured":"Douketis\u00a0JD, Spyropoulos\u00a0AC (2024) Perioperative management of patients taking direct oral anticoagulants: A\u00a0review. JAMA 332:825\u2013834. https:\/\/doi.org\/10.1001\/jama.2024.12708 (Erratum in: JAMA 2024;332:1306. https:\/\/doi.org\/10.1001\/jama.2024.20028)","journal-title":"JAMA"},{"key":"2919_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.chest.2016.08.1462","volume":"151","author":"BT Samuelson","year":"2016","unstructured":"Samuelson\u00a0BT, Cuker\u00a0A, Siegal\u00a0DM, Crowther\u00a0M, Garcia\u00a0DA (2016) Laboratory assessment of the anticoagulant activity of direct oral anticoagulants: A\u00a0systematic review. Chest 151:127\u2013138. https:\/\/doi.org\/10.1016\/j.chest.2016.08.1462","journal-title":"Chest"},{"key":"2919_CR9","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jacc.2020.04.053","volume":"76","author":"GF Tomaselli","year":"2020","unstructured":"Tomaselli\u00a0GF, Mahaffey\u00a0KW, Cuker\u00a0A et\u00a0al (2020) 2020 ACC Expert Consensus Decision Pathway on management of bleeding in patients on oral anticoagulants: A\u00a0report of the American College of Cardiology Solution Set Oversight Committee. JACC Adv 76:594\u2013622. https:\/\/doi.org\/10.1016\/j.jacc.2020.04.053","journal-title":"J Am Coll Cardiol"},{"key":"2919_CR10","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.jacc.2017.08.037","volume":"70","author":"C Patrono","year":"2017","unstructured":"Patrono\u00a0C, Morais\u00a0J, Baigent\u00a0C, Collet\u00a0JP, Fitzgerald\u00a0D, Halvorsen\u00a0S, Rocca\u00a0B, Siegbahn\u00a0A, Storey\u00a0RF, Vilahur\u00a0G (2017) Antiplatelet agents for the treatment and prevention of coronary atherothrombosis. JACC Adv 70:1760\u20131776. https:\/\/doi.org\/10.1016\/j.jacc.2017.08.037","journal-title":"J Am Coll Cardiol"},{"key":"2919_CR11","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3238\/arztebl.m2022.0342","volume":"119","author":"BA Aulinger","year":"2022","unstructured":"Aulinger\u00a0BA, Saner\u00a0FH, Stark\u00a0K, Mayerle\u00a0J, Lange\u00a0CM (2022) Platelet aggregation inhibitors and anticoagulants in gastroenterological and visceral surgical procedures. Dtsch Arztebl Int 119:851\u2013860. https:\/\/doi.org\/10.3238\/arztebl.m2022.0342","journal-title":"Dtsch Arztebl Int"},{"key":"2919_CR12","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1001\/jama.2021.0716","volume":"325","author":"H Kamran","year":"2021","unstructured":"Kamran\u00a0H, Jneid\u00a0H, Kayani\u00a0WT, Virani\u00a0SS, Levine\u00a0GN, Nambi\u00a0V, Khalid\u00a0U (2021) Oral antiplatelet therapy after acute coronary syndrome: A review. JAMA 325:1545\u20131555. https:\/\/doi.org\/10.1001\/jama.2021.0716 (Erratum in: JAMA 2021;326:190. https:\/\/doi.org\/10.1001\/jama.2021.9484)","journal-title":"JAMA"},{"key":"2919_CR13","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1093\/eurheartj\/ehac270","volume":"43","author":"S Halvorsen","year":"2022","unstructured":"Halvorsen\u00a0S, Mehilli\u00a0J, Cassese\u00a0S et\u00a0al (2022) 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J Qual Care Clin Outcomes 43:3826\u20133924. https:\/\/doi.org\/10.1093\/eurheartj\/ehac270 (Erratum in: Eur Heart J 2023;44:4421. https:\/\/doi.org\/10.1093\/eurheartj\/ehad577)","journal-title":"Eur Heart J"},{"key":"2919_CR14","unstructured":"Deutsche Gesellschaft f\u00fcr Kardiologie (DGK) et\u00a0al (2025) S3-Leitlinie Vorhofflimmern. https:\/\/register.awmf.org (AWMF-Registernr. 019\u2013014, Version 1.0)"},{"key":"2919_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2026.03.009","author":"N Johner","year":"2026","unstructured":"Johner\u00a0N, Notaristefano\u00a0F, Vlachos\u00a0K et\u00a0al (2026) Anticoagulation and thromboembolic risk management in pharmacological and electrical cardioversion of atrial fibrillation: State of the evidence and knowledge gaps. Trends Cardiovasc Med. https:\/\/doi.org\/10.1016\/j.tcm.2026.03.009 (Epub ahead of print)","journal-title":"Trends Cardiovasc Med"},{"key":"2919_CR16","doi-asserted-by":"publisher","first-page":"e923","DOI":"10.1161\/CIR.0000000000000968","volume":"143","author":"CG Benesch","year":"2021","unstructured":"Benesch\u00a0CG, Glance\u00a0LG, Derdeyn\u00a0CP et\u00a0al (2021) Perioperative neurological evaluation and management to lower the risk of acute stroke in patients undergoing noncardiac, nonneurological surgery: A scientific statement from the American Heart Association\/American Stroke Association. Circulation 143:e923\u2013e946. https:\/\/doi.org\/10.1161\/CIR.0000000000000968","journal-title":"Circulation"},{"key":"2919_CR17","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","volume":"162","author":"JD Douketis","year":"2022","unstructured":"Douketis\u00a0JD, Spyropoulos\u00a0AC, Murad\u00a0MH et\u00a0al (2022) Perioperative management of antithrombotic therapy: An American College of Chest Physicians clinical practice guideline. Chest 162:e207\u2013e243. https:\/\/doi.org\/10.1016\/j.chest.2022.07.025 (Erratum in: Chest 2023;164:267. https:\/\/doi.org\/10.1016\/j.chest.2023.05.019)","journal-title":"Chest"},{"key":"2919_CR18","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian\u00a0A, Beyersdorf\u00a0F, Praz\u00a0F et\u00a0al (2022) 2021 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J Qual Care Clin Outcomes 43:561\u2013632. https:\/\/doi.org\/10.1093\/eurheartj\/ehab395 (Erratum in: Eur Heart J 2022;43:2022. https:\/\/doi.org\/10.1093\/eurheartj\/ehac051)","journal-title":"Eur Heart J"},{"key":"2919_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2025.12.031","author":"JR Shaw","year":"2026","unstructured":"Shaw\u00a0JR, Abdulrehman\u00a0J, Stella\u00a0SF et\u00a0al (2026) Surgical and procedural bleed risk stratification for anticoagulated patients undergoing planned surgery: Guidance from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis. J\u00a0Thromb Haemost. https:\/\/doi.org\/10.1016\/j.jtha.2025.12.031 (Epub ahead of print)","journal-title":"J Thromb Haemost"},{"key":"2919_CR20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jacc.2016.11.024","volume":"69","author":"JU Doherty","year":"2017","unstructured":"Doherty\u00a0JU, Gluckman\u00a0TJ, Hucker\u00a0WJ, Januzzi\u00a0JL Jr, Ortel\u00a0TL, Saxonhouse\u00a0SJ, Spinler\u00a0SA (2017) 2017 ACC Expert Consensus Decision Pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: A report of the American College of Cardiology Clinical Expert Consensus Document Task Force. JACC Adv 69:871\u2013898. https:\/\/doi.org\/10.1016\/j.jacc.2016.11.024","journal-title":"J Am Coll Cardiol"},{"key":"2919_CR21","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s00108-018-0447-9","volume":"59","author":"SM Schellong","year":"2018","unstructured":"Schellong\u00a0SM, Riess\u00a0H, Spannagl\u00a0M, Omran\u00a0H, Schwarzbach\u00a0M, Langer\u00a0F, Gogarten\u00a0W, Bramlage\u00a0P, Bauersachs\u00a0RM (2018) \u00dcberbr\u00fcckende Antikoagulation bei Patienten unter Vitamin-K-Antagonisten: Eine Bestandsaufnahme. Inn Med 59:744\u2013752. https:\/\/doi.org\/10.1007\/s00108-018-0447-9","journal-title":"Internist (Berl)"}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-026-02919-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-026-02919-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-026-02919-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:05:35Z","timestamp":1793750735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-026-02919-z"}},"subtitle":["Update zum periinterventionellen Management","Update on peri-interventional management"],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2919"],"URL":"https:\/\/doi.org\/10.1007\/s00120-026-02919-z","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"value":"2731-7064","type":"print"},{"value":"2731-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"27 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Ostermann\n                      : A.\u00a0Finanzielle Interessen: M.\u00a0Ostermann gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Angestelltenverh\u00e4ltnis: Assistenz\u00e4rztin Allgemeine Innere Medizin und Angiologie | UKM Marienhospital Steinfurt.\n                      K.\u00a0Beckmann\n                      : A.\u00a0Finanzielle Interessen: K.\u00a0Beckmann gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestelltenverh\u00e4ltnis:\u00a0| Ober\u00e4rztin Allgemeine Innere Medizin und Angiologie | UKM Marienhospital Steinfurt | Angestelltenverh\u00e4ltnis: Ober\u00e4rztin Allgemeine Innere Medizin und Angiologie | UKM Marienhospital Steinfurt.\n                      L.-M.\u00a0Krabbe\n                      : A.\u00a0Finanzielle Interessen: Referentenhonorar und Kongressunterst\u00fctzung: Amgen | Apogepha | Astellas | AstraZeneca | Bayer | BMS | Janssen Cilag | Novartis | Merck Health | MSD | Pfizer | Roche. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Angestelltenverh\u00e4ltnis: Chef\u00e4rztin Klinik f\u00fcr Urologie | Vivantes Humboldt Klinikum Berlin | Vivantes Netzwerk f\u00fcr Gesundheit | Klinik f\u00fcr Urologie, Berlin.\n                      B.\u00a0Krabbe\n                      : A.\u00a0Finanzielle Interessen: Vortrags\u2011\/Referentenhonorare: Bayer Vital GmbH | LEO-Pharma | Pfizer Pharma GmbH | Viatris.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestelltenverh\u00e4ltnis: Chefarzt Allgemeine Innere Medizin und Angiologie | \u00c4rztlicher Direktor, UKM Marienhospital Steinfurt | Mitgliedschaften\/Funktionen: DGA\/Beirat, DEGUM (erweiterter Vorstand, Sprecher Arbeitskreis Vaskul\u00e4rer Ultraschall), BDI (stellvertretender Sprecher Sektion Angiologie), Deutsche Gesellschaft f\u00fcr Phlebologie und Lymphologie.","order":2,"name":"Ethics","label":"Autorinnen und Autoren","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":3,"name":"Ethics","label":"Wissenschaftliche Leitung","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":4,"name":"Ethics","label":"Der Verlag","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}